| Display title | Chemistry:Chlorodehydromethylandrostenediol |
| Default sort key | Chlorodehydromethylandrostenediol |
| Page length (in bytes) | 6,279 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 515548 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>JTerm |
| Date of page creation | 23:01, 5 February 2024 |
| Latest editor | imported>JTerm |
| Date of latest edit | 23:01, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Chlorodehydromethylandrostenediol (CDMA), also known as 4-chloro-17α-methylandrost-1,4-diene-3β,17β-diol, is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 4-androstenediol that was never marketed. It was first encountered in 2005 when it was introduced... |
